All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab (MATCH Study)
Disease/Condition   Pediatric Hematology/Oncology,Cancer,Lymphoma,Lymphatic and Spleen Diseases,Epstein-Barr Virus (EBV),Lymphoproliferative Disorders,Immune System Diseases
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   David Loeb, MD
Contact Name   Elodie Benard
Contact Email   ebenard@montefiore.org
Protocol Number   16-10-211-01
Inclusion/Notes   This Information was obtained from ClinicalTrials.gov
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Pediatric Hematologic Oncology - post transplant cancer
Adult, Pediatric, Both   Pediatric